• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Microcomputer programs for physiologically-based pharmacokinetic (PB-PK) modeling.

作者信息

Dong M H

机构信息

Worker Health and Safety Branch, California Department of Pesticide Regulation, Sacramento 95814.

出版信息

Comput Methods Programs Biomed. 1994 Nov;45(3):213-21. doi: 10.1016/0169-2607(94)90205-4.

DOI:10.1016/0169-2607(94)90205-4
PMID:7705079
Abstract

Physiologically-based pharmacokinetic (PB-PK) models are each defined as a set of mathematical equations offering a fairly comprehensive time course of a chemical's disposition in several pre-selected anatomical compartments. Each of these compartments has its characteristic blood flow, volume, tissue-blood partition coefficient, and metabolic or clearance rate constants that together are deemed responsible for a chemical's disposition in that region. Numerous investigators have used these models to predict tissue dose in the animal or human body in recent years. This simulation technique, if proven effective, will eventually reduce the large number of animals that are required in the costly classic, in vivo studies to be conducted for chemical disposition or metabolism. This communication offers 2 affordable micro-computer programs which can be used as a practical simulation tool in further exploring the application of PB-PK modeling in chemical risk assessment. These 2 programs are written especially for investigators who prefer to have some appreciation of the required computer simulation first before committing themselves to using more advanced, expensive simulation software packages that are commercially available.

摘要

相似文献

1
Microcomputer programs for physiologically-based pharmacokinetic (PB-PK) modeling.
Comput Methods Programs Biomed. 1994 Nov;45(3):213-21. doi: 10.1016/0169-2607(94)90205-4.
2
A PC-based graphical simulator for physiological pharmacokinetic models.
Comput Methods Programs Biomed. 1995 Apr;46(3):245-55. doi: 10.1016/0169-2607(95)01624-3.
3
KINI: a one compartment intravenous pharmacokinetic analysis program.KINI:一个单室静脉注射药代动力学分析程序。
Comput Methods Programs Biomed. 1994 Mar;42(3):157-65. doi: 10.1016/0169-2607(94)90126-0.
4
MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes.MicroPharm-K,一个用于药代动力学过程分析与模拟的微型计算机交互式程序。
Pharm Res. 1995 Aug;12(8):1225-30. doi: 10.1023/a:1016280430580.
5
Lumping in pharmacokinetics.药代动力学中的归并。
J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):719-36. doi: 10.1007/s10928-005-0054-y.
6
A spreadsheet program for modeling quantitative structure-pharmacokinetic relationships for inhaled volatile organics in humans.一个用于模拟人类吸入挥发性有机物的定量结构-药代动力学关系的电子表格程序。
SAR QSAR Environ Res. 2005 Feb-Apr;16(1-2):63-77. doi: 10.1080/10629360412331319880.
7
Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.用于毒理学和风险评估的基于生理的药代动力学和基于生理的药效学模型的开发。
Toxicol Lett. 1995 Sep;79(1-3):35-44. doi: 10.1016/0378-4274(95)03355-o.
8
PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.制药研究和制造商协会(PHRMA)与美国疾病控制与预防中心(CPCDC)关于人体药代动力学预测模型的倡议,第5部分:使用基于生理学的药代动力学建模方法预测人体血浆浓度-时间曲线
J Pharm Sci. 2011 Oct;100(10):4127-57. doi: 10.1002/jps.22550. Epub 2011 May 3.
9
Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.使用概率边界法估算吸入挥发性有机化合物的个体间药代动力学变异性因子。
Regul Toxicol Pharmacol. 2007 Jun;48(1):93-101. doi: 10.1016/j.yrtph.2007.01.008. Epub 2007 Feb 4.
10
A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species.
Arch Toxicol. 2006 Nov;80(11):719-31. doi: 10.1007/s00204-006-0114-0. Epub 2006 May 23.